We think that its over-expression plays a causal role in maintaining the poorly differentiated phenotype of cancer cells by inhibiting differentiation genes (it is GATA3 and FoxA1 in breast cancer cells) in the G1 phase, and activating the pluripotency genes, as cells progress through S and G2 phases. Here, FOXA1 is linked to breast cancer.